XML 36 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Description of the Business and Liquidity (Details)
$ in Thousands, € in Millions
1 Months Ended 3 Months Ended
Jul. 30, 2021
USD ($)
Jul. 30, 2021
EUR (€)
May 11, 2021
USD ($)
tranche
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Mar. 31, 2022
USD ($)
shares
Mar. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
shares
Liquidity                
Net loss           $ 19,361 $ 27,141  
Accumulated deficit           430,066   $ 410,705
Proceeds from Lines of Credit           $ 75,000    
Common stock, shares authorized | shares           150,000,000   150,000,000
Oaktree Capital Management LP Credit Agreement                
Liquidity                
Term of loan facility     5 years          
Maximum borrowing capacity available under the credit agreement     $ 125,000          
Number of tranches | tranche     5          
Proceeds from Lines of Credit     $ 15,000 $ 30,000   $ 30,000    
Additional borrowing capacity available, subject to certain milestone events     $ 50,000          
Oaktree Capital Management LP Credit Agreement | Funding of the tranche A- 2 term loans until the funding of the tranche B term loans                
Liquidity                
Minimum liquidity to be maintained           15,000    
BARDA Contract                
Liquidity                
Maximum amount to be awarded under the contract         $ 51,000      
Contract base period         2 years      
Amount of funding to be provided during contract base period         $ 21,000      
Amount of additional funding to be provided following successful completion of clinical trial and preclinical studies in base period         30,000      
Cost sharing, amount         33,000      
Cost sharing, BARDA amount         $ 51,000      
Contract period-of-performance         5 years      
Collaboration Agreement with Orion                
Liquidity                
Upfront fee received $ 29,600 € 25.0            
R&D reimbursement and cash milestone payments to be received | €   € 97.0            
Number of days from receipt of the final report, in which the collaboration agreement may be terminated 90 days 90 days            
Percentage of upfront fee which must be refunded in the event of termination   75.00%            
Term Loan Tranche B | Oaktree Capital Management LP Credit Agreement                
Liquidity                
Proceeds from Lines of Credit           $ 30,000    
Common Stock                
Liquidity                
Issuance of common stock (in shares) | shares           123,255